Back to search
FDAFDA · Food and drugs·Recall number D-0753-2021

Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 0853, NDC 68382-095-05

Published August 25, 2021 · Recall initiated: August 13, 2021

Summary

FDA records drug Class II recall D-0753-2021, published August 25, 2021 and initiated August 13, 2021. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Terminated; Reported quantity: 2880 bottles; Lot: Z006279, exp 12/31/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle

What to do

Voluntary: Firm initiated · Letter

Get an email if CARVEDILOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CARVEDILOL
Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
Nationwide in the US
Lot
Z006279, exp 12/31/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 0853, NDC 68382-095-05 recalled?

Yes. FDA published recall D-0753-2021 on August 25, 2021. Reported hazard: Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CARVEDILOL.